These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29780775)

  • 1. Optimal cutoff level of serum squamous cell carcinoma antigen to detect recurrent cervical squamous cell carcinoma during post-treatment surveillance.
    Oh J; Bae JY
    Obstet Gynecol Sci; 2018 May; 61(3):337-343. PubMed ID: 29780775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of squamous cell carcinoma antigen for predicting tumor recurrence in cervical squamous cell carcinoma patients.
    Ryu HK; Baek JS; Kang WD; Kim SM
    Obstet Gynecol Sci; 2015 Sep; 58(5):368-76. PubMed ID: 26430661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on the preoperative value of serum SCC-Ag in predicting the stromal invasion of cervical squamous cell carcinoma.
    Qin L
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):9167-9171. PubMed ID: 37184678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can serial evaluation of serum SCC-Ag-level predict tumor recurrence and patient survival in squamous-cell carcinoma of uterine cervix treated with definitive chemoradiotherapy? A multi-institutional analysis.
    Choi KH; Yu M; Jeong S; Lee JH
    Int J Clin Oncol; 2020 Jul; 25(7):1405-1411. PubMed ID: 32221801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttreatment squamous cell carcinoma antigen predicts treatment failure in patients with cervical squamous cell carcinoma treated with concurrent chemoradiotherapy.
    Wang W; Liu X; Hou X; Lian X; Liu Z; Shen J; Sun S; Yan J; Miao Z; Wang D; Meng Q; Fu J; Zhang F; Qiu J; Hu K
    Gynecol Oncol; 2019 Nov; 155(2):224-228. PubMed ID: 31500891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix.
    Liu CZ; Zeng HX; Zhao JJ; Rong Y; Mo ZL; Li LA; Zhang JQ
    Int J Gynecol Cancer; 2017 Jun; 27(5):994-1000. PubMed ID: 28498239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis.
    Choi KH; Lee SW; Yu M; Jeong S; Lee JW; Lee JH
    J Gynecol Oncol; 2019 Jan; 30(1):e1. PubMed ID: 30479085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of serum squamous cell carcinoma antigen for follow-up monitoring of cervical cancer patients who were treated by concurrent chemoradiotherapy.
    Yoon SM; Shin KH; Kim JY; Seo SS; Park SY; Moon SH; Cho KH
    Radiat Oncol; 2010 Sep; 5():78. PubMed ID: 20840788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
    Li Q; Liu S; Liu H; Zhang J; Guo S; Wang L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus.
    Kanda M; Koike M; Shimizu D; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Omae K; Yamada S; Nakayama G; Kodera Y
    Ann Surg Oncol; 2020 Apr; 27(4):1233-1240. PubMed ID: 31650302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation Between Squamous Cell Carcinoma Antigen Level and the Clinicopathological Features of Early-Stage Cervical Squamous Cell Carcinoma and the Predictive Value of Squamous Cell Carcinoma Antigen Combined With Computed Tomography Scan for Lymph Node Metastasis.
    Xu D; Wang D; Wang S; Tian Y; Long Z; Ren X
    Int J Gynecol Cancer; 2017 Nov; 27(9):1935-1942. PubMed ID: 28914639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with locally advanced cervical cancer treated with radiation or chemoradiation.
    Oh J; Lee HJ; Lee TS; Kim JH; Koh SB; Choi YS
    Obstet Gynecol Sci; 2016 Jul; 59(4):269-78. PubMed ID: 27462593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
    Li D; Xu XX; Yan DD; Yuan SH; Lou HM
    Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
    [No Abstract]   [Full Text] [Related]  

  • 14. Utility of serum squamous cell carcinoma antigen levels at the time of recurrent cervical cancer diagnosis in determining the optimal treatment choice.
    Shimura K; Mabuchi S; Yokoi T; Sasano T; Sawada K; Hamasaki T; Kimura T
    J Gynecol Oncol; 2013 Oct; 24(4):321-9. PubMed ID: 24167667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment response evaluation through the combination of contrast-enhanced ultrasound and squamous cell carcinoma antigen in cervical cancer.
    Hong R; Luo L; Xu X; Huang K; Zhao H; Huang L; Wang Y; Li F
    Quant Imaging Med Surg; 2024 Oct; 14(10):7587-7599. PubMed ID: 39429563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of serum carcinoembryonic antigen and squamous cell carcinoma antigen in patients with esophageal squamous cell carcinoma undergoing radical esophagectomy.
    Hu J; Kuang P; Chen D; Chen Y; Wen Z
    Transl Cancer Res; 2020 Apr; 9(4):2460-2471. PubMed ID: 35117605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of serum squamous cell carcinoma antigen in the diagnosis, treatment and prognosis of cervical squamous cell carcinoma].
    Luan XM; Zhang Y; Wang SZ; Wang N; Li W; Zhang Q; Wei H; Zhang SL
    Zhonghua Yi Xue Za Zhi; 2012 May; 92(19):1330-3. PubMed ID: 22883121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum expression level of squamous cell carcinoma antigen, highly sensitive C-reactive protein, and CA-125 as potential biomarkers for recurrence of cervical cancer.
    Guo S; Yang B; Liu H; Li Y; Li S; Ma L; Liu J; Guo W
    J Cancer Res Ther; 2017; 13(4):689-692. PubMed ID: 28901315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: A systematic review and meta-analysis.
    Charakorn C; Thadanipon K; Chaijindaratana S; Rattanasiri S; Numthavaj P; Thakkinstian A
    Gynecol Oncol; 2018 Jul; 150(1):190-200. PubMed ID: 29606483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of squamous cell carcinoma antigen levels in invasive cervical carcinoma.
    Maiman M; Feuer G; Fruchter RG; Shaw N; Boyce J
    Gynecol Oncol; 1989 Sep; 34(3):312-6. PubMed ID: 2767521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.